University Biotechnology Report: Strategy, Innovation and CSR

This report examines the concepts of strategy, innovation, and Corporate Social Responsibility (CSR) within the biotechnology field. It references Michael Porter's work on strategy and shared value, emphasizing the importance of differentiating from competitors and creating value for both the company and society. The report analyzes the relationship between CSR and competitive advantage, highlighting the role of leaders in adopting effective strategies. It discusses the concept of shared value, exemplified by Roche Pharmaceuticals, and how it influences decision-making and organizational unity. The report contrasts strategy and innovation, concluding that strategy can be innovative but innovation is not always strategic. It stresses the importance of both for organizational success and competitive advantage and answers a question regarding innovative strategy design. The report references various sources to support its analysis.